Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 59 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Papaefthymiou, Apostolis [Clear All Filters]
Rodent models of obesity..
Minerva Endocrinol. 45(3), 243-263.
(2020). Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents..
Expert Opin Pharmacother. 21(3), 247-251.
(2020). Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial..
Medicina (Kaunas). 56(7),
(2020). Update on the association between non-alcoholic fatty liver disease and Helicobacter pylori infection..
Int J Clin Pract. e13737.
(2020). Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease..
Minerva Endocrinol (Torino).
(2021). Helicobacter pylori infection and diabetes mellitus..
Diabetes Metab Syndr. 15(3), 845-846.
(2021). Helicobacter pylori-Related Metabolic Parameters and Premalignant Gastric Mucosa Histological Lesions in Swiss Bariatric Patients..
Microorganisms. 9(7),
(2021). Impact of Helicobacter pylori-related Metabolic Syndrome and Gastroesophageal Reflux Disease on the Risk of Acute Myocardial Infarction..
J Neurogastroenterol Motil. 27(1), 147-148.
(2021). Impact of -Related Metabolic Syndrome Parameters on Arterial Hypertension..
Microorganisms. 9(11),
(2021). Impact of -related Microbial Dysbiosis in the Pathogenesis of Metabolic Syndrome and Gastrointestinal Dysmotility Disorders..
J Neurogastroenterol Motil. 27(4), 653-654.
(2021). Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents..
J Crohns Colitis.
(2021). Potential impact of Helicobacter pylori-related metabolic syndrome and Galectin-3 on liver, chronic kidney and brain disorders..
Metabolism. 154736.
(2021). A potential impact of Helicobacter pylori-related sarcopenia on severity of portal hypertension..
Liver Int.
(2021). Role of autophagy in gastric carcinogenesis..
World J Gastrointest Oncol. 13(10), 1244-1262.
(2021). The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis..
Neurochem Int. 144, 104938.
(2021).
(2022).
Diagnostic approach to -related gastric oncogenesis..
Ann Gastroenterol. 35(4), 333-344.
(2022). Emerging parameters relevant to the management of antimicrobial-resistant Helicobacter pylori infection..
Intern Med J. 52(9), 1654-1655.
(2022). GM-CSF as a potential candidate of a vaccine-induced reduction of Helicobacter pylori infection..
Helicobacter. 27(3), e12884.
(2022). Impact of Active Helicobacter pylori Infection-related Metabolic Syndrome on Systemic Arterial Hypertension..
Arq Bras Cardiol. 119(3), 502-504.
(2022). Letter to the Editor Regarding "The Association of Helicobacter pylori, Eradication, and Early Complications of Laparoscopic Sleeve Gastrectomy" by Abeid et al..
Obes Surg. 32(6), 2079-2080.
(2022). Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease..
Metabolism. 135, 155276.
(2022). Potential Impact of Helicobacter pylori Infection on Pancreatic Cancer Pathophysiology..
J Gastrointest Cancer.
(2022). Potential impact of Helicobacter pylori-related metabolic syndrome on arterial hypertension outcomes..
Am J Hypertens.
(2022). A potential impact of Helicobacter pylori-related metabolic syndrome on early and long-term outcomes of bariatric surgery..
Gastrointest Endosc. 96(6), 1088-1089.
(2022).